Nb. Murphy et al., USE OF AN INVIVO SYSTEM TO DETERMINE THE G418 RESISTANCE PHENOTYPE OFBLOOD-STREAM-FORM TRYPANOSOMA-BRUCEI-BRUCEI TRANSFECTANTS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1167-1170
We determined the level of susceptibility of Trypanosoma brucei brucei
to the aminoglycoside G418 in vivo and demonstrated that it is possib
le to select for G418-resistant transfected T. brucei brucei bloodstre
am parasites in a mouse host by inoculating the drug intraperitoneally
at doses between 40 and 80 mg/kg of body weight daily for 3 days. The
ability to select for transfectants in vivo offers new possibilities
for studies on genetic recombination in these parasites.